Assessing Nektar Therapeutics (NASDAQ:NKTR) Stock & NKTR-181 Commercial Outlook After 42% Move

Is NKTR stock still a good buy after its 40% move higher, after Nektar Therapeutics (NASDAQ:NKTR) strong NKTR-181 data?

Posted in Biotech Hunter, Healthcare & Biotech, Members, Request Coverage | Tagged , , , | Leave a comment